HB Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
2,049
+46
| +2% | +$24.2K | 0.01% | 504 |
|
|
2025
Q1 | $1.27M | Sell |
2,003
-126
| -6% | -$79.9K | 0.01% | 474 |
|
|
2024
Q4 | $1.52M | Buy |
2,129
+161
| +8% | +$115K | 0.02% | 333 |
|
|
2024
Q3 | $2.07M | Buy |
1,968
+116
| +6% | +$122K | 0.02% | 271 |
|
|
2024
Q2 | $1.95M | Buy |
1,852
+181
| +11% | +$190K | 0.02% | 268 |
|
|
2024
Q1 | $1.61M | Buy |
1,671
+552
| +49% | +$531K | 0.02% | 281 |
|
|
2023
Q4 | $983K | Buy |
1,119
+212
| +23% | +$186K | 0.01% | 320 |
|
|
2023
Q3 | $746K | Buy |
907
+199
| +28% | +$164K | 0.01% | 344 |
|
|
2023
Q2 | $509K | Buy |
708
+6
| +0.9% | +$4.31K | 0.01% | 411 |
|
|
2023
Q1 | $577K | Buy |
702
+154
| +28% | +$127K | 0.01% | 380 |
|
|
2022
Q4 | $395K | Buy |
548
+135
| +33% | +$97.4K | 0.01% | 450 |
|
|
2022
Q3 | $285K | Buy |
+413
| New | +$285K | 0.01% | 452 |
|